ArticleIDCases2026
Amebic liver abscess: A case report.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amebic liver abscess (ALA), caused by Entamoeba histolytica, is the most common extraintestinal manifestation of amebiasis. However, in contemporary clinical practice, diagnosis increasingly relies on serology and polymerase chain reaction (PCR), whereas direct microscopic identification of motile trophozoites in aspirated specimens has become rarely documented. Furthermore, optimal management necessitates complete anti-amebic therapy covering both invasive tissue stages and luminal intestinal colonization to prevent relapse. Here, we report a case of a 25-year-old male with a history of splenectomy and pulmonary tuberculosis, presenting with fever, right upper quadrant pain, and cough. Imaging revealed a right hepatic lobe abscess. While abscess and blood cultures remained sterile, sputum culture grew E. coli. Fresh microscopic examination of the aspirate readily demonstrated motile, erythrophagocytic trophozoites, subsequently confirmed as E. histolytica by sequencing. Although the patient showed initial clinical improvement with metronidazole, he later developed severe bleeding and ulceration of the ascending colon, ultimately requiring partial colectomy. This case underscores the enduring diagnostic value of conventional wet-mount microscopy in the molecular era, offering a rapid and cost-effective tool. Critically, it also highlights a key therapeutic principle ALA treated with a tissue-active agent must be followed by a luminal agent to eradicate intestinal carriage. Failure to do so risks persistent colonic disease, severe complications, or treatment failure, as observed in this patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.